View Older Stories View More Recent Stories

Dec 19, 2016 08:00AM Surface Oncology Announces Collaboration with Dr. John Stagg, a World-Leader in the Adenosine Pathway
Dec 15, 2016 09:00AM Surface Oncology Appoints Robert Ross, MD as Chief Medical Officer
Dec 15, 2016 07:30AM Synlogic Appoints COO and Head of Corporate Development
Dec 9, 2016 10:12AM ProfNet Experts Available on Antibiotic Resistance, Seasonal Affective Disorder, More
Dec 7, 2016 08:30AM Founder and CEO of Replimune Limited Honored with the IPO Education Foundation's 43rd Annual Inventor of the Year Award
Dec 2, 2016 08:00AM Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity in Hematological Disease Models
Nov 16, 2016 07:00AM Magenta Therapeutics Announces $48.5M Series A Financing to Transform Stem Cell Transplant for Immune and Blood Diseases
Nov 10, 2016 08:00AM Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
Nov 2, 2016 08:40AM SaltDNA Adds Desktop Application to Its Secure Mobile Communication Solution for the Enterprise
Nov 1, 2016 08:28AM Signal Genetics (SGNL) to Merge with Miragen Therapeutics
Oct 31, 2016 08:02PM miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Oct 26, 2016 05:00AM IFM Therapeutics Establishes German Subsidiary and Research Site
Sep 30, 2016 04:20PM Global drug development executives converge on Boston for BioPharm America™ 2016
Sep 22, 2016 07:00AM Rodin Expands Leadership Team and Advisory Boards to Advance Novel, Selective HDAC Inhibitors Towards the Clinic
Sep 20, 2016 10:00AM ZappRx Hires Biopharmaceutical Industry Leader as Chief Operating Officer
Sep 14, 2016 07:00AM Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases
Sep 12, 2016 08:00AM Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic
Sep 7, 2016 04:37AM Armored Cloud Announces Partnership with SaltDNA for Enterprise Encrypted Mobile Communication
Sep 6, 2016 07:00AM IFM Therapeutics Appoints Leading Oncology, Immunology, and Chemistry Experts to Founding Scientific Advisory Board
Aug 29, 2016 08:00AM Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation
Aug 2, 2016 08:05AM AVROBIO, Inc. Announces $25 Million Series A Financing to Advance Novel, Clinical-Stage Gene Therapies for Rare Diseases and Cancer
Jul 26, 2016 10:01AM SaltDNA and Copperhead Partner to Provide End-to-End Encrypted Mobile Communications with Full Device Security
Jul 19, 2016 07:00AM Quartet Medicine Appoints Gerhard Koenig, Ph.D., as Chief Executive Officer
Jul 15, 2016 10:50AM Key life science industry thought leaders and new one-day programs elevate offerings at BioPharm America™ 2016
Jul 11, 2016 06:00AM World Renowned Entrepreneur Laura Morse Joins PixarBio’s Board of Directors as PixarBio Prepares for SEC Compliance
Jun 22, 2016 07:00AM IFM Therapeutics Raises $27 Million Series A Financing Led by Atlas Venture and Abingworth
May 11, 2016 07:00PM Form 4 Intellia Therapeutics, For: May 11 Filed by: Atlas Venture Fund IX, L.P.
May 5, 2016 06:31PM Form 3 Intellia Therapeutics, For: May 05 Filed by: Atlas Venture Fund IX, L.P.
Apr 20, 2016 09:07AM Ivan Baker Joins Inmoji as Vice President, Business Development
Mar 23, 2016 08:00AM Synlogic Appoints an Industry Leader Nick Leschly to Its Board of Directors
Mar 17, 2016 10:26AM SaltDNA Introduces First Encrypted Conference Calling Feature for Secure Mobile Communications
Mar 11, 2016 09:03AM Inmoji Secures $5 Million in Series A Funding to Fuel Growth and Innovation in Branded Interactive Emojis for Mobile Messaging
Mar 10, 2016 01:54AM Evotec Achieves Milestone in Collaboration with Padlock Therapeutics
Mar 3, 2016 09:00AM LTG Exam Platform Secures $5.3 Million in Series A Funding to Fuel Strategic Plan for Rapid Expansion
Feb 18, 2016 07:00AM AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases
Feb 17, 2016 07:00AM Synlogic Secures $40 Million in Series B Financing
Feb 16, 2016 06:00AM Crowdynews Adds New Board Members And Creates Advisory Board
Feb 12, 2016 10:56AM Form SC 13G/A Vitae Pharmaceuticals, Filed by: ATLAS VENTURE FUND VI LP
Feb 12, 2016 09:59AM Form SC 13G/A ZAFGEN, INC. Filed by: Atlas Venture Fund VII L P
Feb 12, 2016 09:58AM Form SC 13G/A Egalet Corp Filed by: Atlas Venture Fund VII L P
Feb 11, 2016 09:00AM Machine Learning Company DataRobot Accelerates Growth with $33 Million in New Funding
Feb 10, 2016 07:00AM Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome
Feb 2, 2016 09:30AM Spero Therapeutics Announces $30 Million Series B Preferred Financing
Feb 1, 2016 11:23AM Lexumo Funded to Secure IoT and Embedded Devices, Critical Infrastructure, and Enterprise Applications from Widespread Open Source Vulnerabilities
Jan 28, 2016 08:00AM Vito Palombella, PhD Joins Surface Oncology as Chief Scientific Officer
Jan 22, 2016 10:00AM JenaValve Technology Appoints Pieter Van den Steen As Chief Commercial Officer, General Manager
Jan 20, 2016 09:17AM Upsher-Smith And Saniona Sign Collaboration Agreement For Development Of Novel Therapeutics For Neurological Disorders
Jan 11, 2016 09:00AM Joshua Resnick, MD Joins SV Life Sciences as Partner
Jan 11, 2016 01:15AM Surface Oncology Announces Global Strategic Collaboration to Advance Next-Generation Immunotherapies
Jan 7, 2016 10:00AM JenaValve Technology Appoints Janet M. Fauls As Vice President Of Regulatory Affairs
View More Recent Stories View Older Stories